Paul Leger, MD, Oncology, Washington, DC, MedStar Georgetown University Hospital


Oncology Washington, DC

Genitourinary Oncology


Dr. Leger is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Leger's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology/Oncology, 2017 - 2020
  • Vanderbilt University
    Vanderbilt UniversityResidency, Internal Medicine

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2019 - 2022
  • MD State Medical License
    MD State Medical License 2017 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations


Journal Articles

  • Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation  
    1) Leger P., Chirva S., Nwogu J., Tuner M., Richardson D., Baker P., Leonard M., Erdem H., Olson L., Haas D., Pharmacogent Genomics, 1/28/2018
  • A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma.  
    2) Nakajima E., Leger P., Mayer I., Neuss M., Chism D., Rathmell K, Kidney Cancer, 7/2017
  • Clinical features of acquired resistance in anti-PD-1 therapy  
    3) Wang D., Zeynep E., Ozgun A., Leger P., Zhao S., Ye F., Luke J., Joseph R., Sosman J., Johnson D., Buchbinder E, Cancer Immunology Research, 5/2017
  • Join now to see all

Other Languages

  • Creole, French

Hospital Affiliations